1. Bodley AL, Liu LF (1988) Topoisomerases as novel targets for cancer chemotherapy. Biotechnology 6: 1315
2. Creaven PJ, Allen LM, Muggia FM (1972) Plasma camptothecin (NSC-100880) levels during a 5-day course of treatment: relation to dose and toxicity. Cancer Chemother Rep 56: 573
3. Drewinko B, Freireich EJ, Gottlieb JA (1974) Lethal activity of camptothecin sodium on human lymphoma cells. Cancer Res 34: 747
4. Fukuoka M, Negoro S, Niitani H, Taguchi T (1990) A phase II study of a new camptothecin derivative, CPT-11 in previously untreated non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 9: 226
5. Furuta T, Yokokura T, Mutai M (1978) Antitumor activity of CPT-11 against rat Walker 256 carcinoma. Jpn J Cancer Chemother 15: 2757